S. Charleson et al., STRUCTURAL REQUIREMENTS FOR THE BINDING OF FATTY-ACIDS TO 5-LIPOXYGENASE-ACTIVATING PROTEIN, European journal of pharmacology. Molecular pharmacology section, 267(3), 1994, pp. 275-280
5-Lipoxygenase-activating protein is required for cellular leukotriene
synthesis and is the target of the leukotriene biosynthesis inhibitor
s MK-886 ert-butylthio-1H-indol-2-yl]-2,2-dimethylpropanoic acid) and
MK-591 lin-2-ylmethoxy)-indol-2-yl]-2,2-dimethylpropanoic acid). Recen
t studies demonstrate that 5-lipoxygenase-activating protein binds ara
chidonic acid and stimulates the utilization of this substrate by 5-li
poxygenase. The present study utilizes a radioligand binding assay to
assess the affinity of 5-lipoxygenase-activating protein for arachidon
ic acid and the specificity of the fatty acid binding site on 5-lipoxy
genase-activating protein. Our findings demonstrate that the presence
of a free carboxyl group on fatty acids or leukotriene biosynthesis in
hibitors which interact with 5-lipoxygenase-activating protein is not
required for specific binding to the protein. However, the degree of s
aturation significantly affects the affinity of fatty acids for 5-lipo
xygenase-activating protein.